Aducanumab isn’t the simple solution to the complicated Alzheimer’s crisis
SEBASTIEN BOZON/AFP VIA GETTY IMAGES
What if we could treat Alzheimer's-related mild cognitive impairment with a somewhat effective but costly and risky drug? The answers are discomforting.


No hay comentarios:
Publicar un comentario